Impact of Pre-Transplant Hypomethylating Agents on Reduced-Intensity Conditioning Allogeneic Hematopoietic Cell Transplantation in Myelodysplastic Syndrome With Good or Intermediate-Risk Cytogenetics [0.03%]
低强度预处理方案用于细胞遗传学具有良好或中等风险的骨髓增生异常综合征患者allo-HSCT前使用去甲基化药物的影响分析
Yanal Alnimer,Ayman Qasrawi,Ashley Soule et al.
Yanal Alnimer et al.
Allogeneic stem cell transplant (Allo-SCT) remains the only curative option for patients with myelodysplastic syndrome (MDS). The benefit of cytoreduction with hypomethylating agents (HMAs) prior to reduced-intensity conditioning (RIC) tran...
Disability-Free Survival: A Novel Morbidity Endpoint for Older Adult Allogeneic Hematopoietic Cell Transplantation [0.03%]
无残疾生存：老年成人异基因造血细胞移植受者的新型终点指标
Jorge M Ramos Perez,Haoyue Shan,Dongyun Yang et al.
Jorge M Ramos Perez et al.
Transplant-related morbidity remains a major barrier to broader application of allogeneic hematopoietic cell transplantation (HCT) in older adults. The frequency and importance of physical disabilities early after HCT have not been well-cha...
Rectal Colonization with Multidrug-Resistant Organisms and Subsequent Bloodstream Infections in Hematological Patients Undergoing Cellular Therapies [0.03%]
造血干细胞移植患者多重耐药菌直肠定植及后续血流感染相关性研究
Pinelopi Kazakou,Charalampos Charalampidis,Ioannis Konstantellos et al.
Pinelopi Kazakou et al.
Bacterial infections, especially bloodstream infections (BSIs), compromise the overall survival of patients with hematological malignancies undergoing cellular therapies. The interplay between rectal colonization by different types of multi...
Comment on "Caring for the Hematopoietic Stem Cell Transplantation Population: Clinician Perspectives on Challenges and Opportunities in Psychosocial Care Delivery" [0.03%]
关于“造血干细胞移植人群的照护：临床医师视角下的心理社会照护挑战与机遇”的评论
Monalisha Pal,Swati Bhatiya,Shanthi Ida Sophia
Monalisha Pal
Risk Factors for the Development of Avascular Necrosis Following Hematopoietic Cell Transplantation for Sickle Cell Disease [0.03%]
干细胞移植治疗镰状细胞病后发生股骨头缺血性坏死的危险因素分析
Rohaum Hamidi,Vineetha Reddy Nallagatla,Jingchen Liang et al.
Rohaum Hamidi et al.
Reply to: G-CSF Timing After CAR-T: Early, Late - or Just Irrelevant? [0.03%]
G-CSF使用时机：CAR-T治疗后早期、晚期或无关紧要？—回应文章
Marshall Winget,Hunter Sowell,Katie Gatwood
Marshall Winget
Gene therapy for sickle cell disease: Practice recommendations from the American Society for Transplantation and Cellular Therapy and the International Society for Cell & Gene Therapy [0.03%]
美国移植与细胞治疗学会和国际细胞与基因疗法学会关于镰状细胞病基因治疗实践推荐意见
Akshay Sharma,Adetola Kassim,Alexis Thompson et al.
Akshay Sharma et al.
Gene therapy has emerged as a transformative treatment option for individuals with sickle cell disease (SCD), with recent regulatory approvals marking a pivotal shift in clinical care. However, the complexity of patient selection, stem cell...
Phase I Trial of Venetoclax and BEAM Followed by Autologous Stem Cell Transplant for High-Risk Non-Hodgkin Lymphoma [0.03%]
用于高风险非霍奇金淋巴瘤患者的维奈克拉联合BEAM方案自体移植I期临床试验
Joseph E Maakaron,Qiuhong Zhao,Jayalakshmi P Balakrishna et al.
Joseph E Maakaron et al.
Transportability to the European Population of Efficacy of Belumosudil as Compared With Physician's Choice of Best Available Therapy for the Treatment of Chronic Graft Versus Host Disease [0.03%]
与最佳可用治疗方法相比，贝尔莫苏迪尔在中国和欧洲克隆病受者中的疗效外推性：治疗慢性移植物抗宿主病的多国、随机、3 期试验
Daniel Wolff,Carlos Solano,David Michonneau et al.
Daniel Wolff et al.
Belumosudil was approved by US Food and Drug Administration in July 2021 for the treatment of relapsed/refractory chronic graft-versus-host disease (cGVHD) in patients aged ≥12 years after failure of at least 2 prior lines of therapy (LOTs...
Cognitive Recovery Following Immune Effector Cell-Associated Neurotoxicity Syndrome in the First 6 Mo after Chimeric Antigen Receptor T-Cell Therapy [0.03%]
CAR-T细胞治疗后前六个月免疫效应细胞相关神经毒性综合征的认知恢复状况
Christina Kazzi,Sarah P Griffith,Katherine Y Ko et al.
Christina Kazzi et al.
Chimeric antigen receptor T-cell (CAR-T) therapy is associated with immune effector cell-associated neurotoxicity syndrome (ICANS), which can manifest as acute and sub-acute cognitive dysfunction. Few studies have investigated cognitive rec...